DrugPatentWatch Database Preview
Drugs in Development Information for Hepatitis A Vaccine
Email this page to a colleague
See Plans and PricingWhat is the drug development status for Hepatitis A Vaccine?
Hepatitis A Vaccine is an investigational drug.
There have been 4 clinical trials for Hepatitis A Vaccine.
The most recent clinical trial was a Phase 2 trial.
The most common disease conditions in clinical trials are HIV Infections, Urinary Bladder Neoplasms, and Colonic Neoplasms. The leading clinical trial sponsors are National Institute of Allergy and Infectious Diseases (NIAID), MacroGenics, and National Cancer Institute (NCI).
Summary for Hepatitis A Vaccine
| US Patents | 0 |
| International Patents | 0 |
| US Patent Applications | 0 |
| WIPO Patent Applications | 0 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (1969-12-31) |
| Vendors | 0 |
Recent Clinical Trials for Hepatitis A Vaccine
| Title | Sponsor | Phase |
|---|---|---|
| Phase 1 Study of MGD010 in Healthy Subjects | MacroGenics | Phase 1 |
| Improving the Immune System With Human IL-7 Vaccine in Older Subjects Who Have Had Chemotherapy | National Cancer Institute (NCI) | Phase 2 |
| A Study to Compare the Effectiveness of a Four Drug Anti-HIV Regimen Given Alone or in Combination With GM-CSF or IL-12 to HIV-Positive Patients | National Institute of Allergy and Infectious Diseases (NIAID) | N/A |
Clinical Trial Summary for Hepatitis A Vaccine
Top disease conditions for Hepatitis A Vaccine
Top clinical trial sponsors for Hepatitis A Vaccine
US Patents for Hepatitis A Vaccine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
